Form 4 for HIMS Hims & Hers Health, Inc.
Accepted 2026-04-22 17:24:06 ET · period of report 2026-04-20 · accession 0001907056-26-000016 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DMT | 2026-04-22 17:24 | 2026-04-20 | HIMS | Okupe Oluyemi | CFO | M - OptEx | $8.65 | +12.6K | 282.6K | +5% | +$108.5K |
| DT | 2026-04-22 17:24 | 2026-04-20 | HIMS | Okupe Oluyemi | CFO | S - Sale+OE | $29.96 | -19.6K | 263.0K | -7% | -$588.6K |
| DMT | 2026-04-22 17:24 | 2026-04-20 | HIMS | Okupe Oluyemi | CFO | M - OptEx | $0.00 | -12.6K | 36.0K | -26% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Class A Common Stock | 2026-04-20 | M | A | 5,553 | $5.01 | 275,599 | D | — | — | (F1) The stock option exercises and sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted on May 21, 2025 by the Reporting Person. |
| 2 | Common | Class A Common Stock | 2026-04-20 | M | A | 7,000 | $11.53 | 282,599 | D | — | — | (F1) The stock option exercises and sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted on May 21, 2025 by the Reporting Person. |
| 3 | Common | Class A Common Stock | 2026-04-20 | S | D | 19,645 | $29.96 | 262,954 | D | — | — | (F1) The stock option exercises and sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted on May 21, 2025 by the Reporting Person. (F2) Price reported constitutes the average weighted price of shares sold. Shares were sold at varying prices in the range of $29.95 - $30.005. The Reporting Person hereby undertakes, upon request of the Commission, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price. |
| 4 | Derivative | Stock Option (right to buy) | 2026-04-20 | M | D | 5,553 | $0.00 | 123,850 | D | $5.01 · — to 2032-02-23 | 5,553 Class A Common Stock | (F1) The stock option exercises and sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted on May 21, 2025 by the Reporting Person. (F3) The stock options are fully vested and exercisable. |
| 5 | Derivative | Stock Option (right to buy) | 2026-04-20 | M | D | 7,000 | $0.00 | 35,996 | D | $11.53 · — to 2033-03-01 | 7,000 Class A Common Stock | (F1) The stock option exercises and sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted on May 21, 2025 by the Reporting Person. (F4) The options are subject to a service-based vesting requirement, which shall be satisfied over a 4-year period, with 1/48th of the options vesting monthly, beginning on April 1, 2023. |